Is it important to adapt neoadjuvant chemotherapy to the visible clinical response? An open randomized phase II study comparing response-guided and standard treatments in HER2-negative operable breast cancer
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Christian Garbar Catherine Abrial |
| Publication date | January 30, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |